Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Visit the company website

 

Bullboard - Investor Discussion Forum Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s):  VYYRF

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX... see more

TSXV:VM - Post Discussion

Voyageur Pharmaceuticals Ltd > VM: Insiders Sell More Shares
View:
Post by Flagshipzilla on Jan 31, 2022 10:18am

VM: Insiders Sell More Shares

Filed 2022-01-31 06:46 Tx date 2022-01-28 $VM
Voyageur Pharmaceuticals Ltd.
Abraham, Trent
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-12,000
-100,000 vol
$0.12 each
2,020,166  
Filed 2022-01-31 06:45 Tx date 2022-01-27 $VM
Voyageur Pharmaceuticals Ltd.
Abraham, Trent
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-12,000
-100,000 vol
$0.12 each
2,120,166  
Filed 2022-01-31 06:44 Tx date 2022-01-26 $VM
Voyageur Pharmaceuticals Ltd.
Abraham, Trent
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-12,000
-100,000 vol
$0.12 each
2,220,166
Comment by oldtrouf on Jan 31, 2022 3:11pm
Now there's a vote of confidence for the company!  Not the sharpest knife in the drawer this one.  He dumped 300k @ .12 when he could have probably got .15 a few weeks ago.  Either way just another blow to the reputation of the company....I wonder what this guy knows???
Comment by biggdogg on Jan 31, 2022 3:47pm
I reached out, it sounds like a financial issue for this director. It sounds like tough times can effect the directors in this company too.
Comment by Flagshipzilla on Feb 01, 2022 3:52am
The company hasn't accomplished anything for many years...  The only reason people know about it is because I promoted it a year ago when every idiots was trowing money in the market.  I sold close to a million shares when it went over 24 cents.  I spoke to someone at the company and it went nowhere.  So I stopped supporting it and killed my plans to buy 2.5 million shares.
Comment by biggdogg on Feb 01, 2022 8:20pm
LOL, really!? The company has not accomplish anything? How about proving up the highest grade barium in the world, having the brains to create a high margin Pharma company versus a low margin mining company, completing an engineering economic study on creating the highest purity natural barium in the world, health Canada approvals, FDA pending this year, EU and Japan drug license pending, lined up ...more  
Comment by Flagshipzilla on Feb 01, 2022 3:56am
To further clatrify, the company had half the amount of shares back then and without the company being involved I was market making the stock by creating liquidity through a series of buy and sell transactions on a daily basis.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.VM

follow v.vm on


Voyageur Pharmaceuticals Deck 2024..

The Watchlist

Voyageur Pharmaceuticals | The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

COMPELLING
VALUE PROPOSITION

  • Only pharmaceutical company in the world that owns long-term supply of barium and iodine
  • Natural barium and iodine resources meet increasingly limited global supply and risk
  • Multi-billion-dollar global market for contrast media
  • Poised to obtain significant market share by offering high-quality, lower-cost products
  • Favorable regulatory pathway allows rapid commercialization
  • Highly experienced team has positioned the company for profitable commercial success

Contact Us

Brent Willis, CEO
Brent@Vpharma.ca

Address:
Suite 1600 Dome Tower, 333 7th Avenue S.W.
Calgary, Alberta
T2P 2Z1